Skip to content

Actinium Pharmaceuticals, Inc.

ATNM

CIK 0001388320 · Pharmaceutical Preparations · NYSE

  • Cactus Ventures, Inc. (until 2013-03-29)
← back to feed
Revenue (TTM)
$1.12M
+11.1% YoY Q1 May 2026
Net Income (TTM)
−$33.47M
+11.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.07
+14.2% YoY Q1 May 2026
Gross Margin
0.0%
Q1 May 2026
Operating Margin
-3,190.7%
Q1 May 2026
Net Margin
-2,988.3%
Q1 May 2026
Free Cash Flow (TTM)
−$35.99M
Q1 May 2026
Cash
$42.13M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
31.37M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings